Heteroresistance: A cause of unexplained antibiotic treatment failure?

The high prevalence of antibiotic heteroresistance in pathogenic bacteria is mainly caused by gene amplification

(2019) Hervé Nicoloff et al.   Nature Microbiology

Colistin heteroresistance and the involvement of the PmrAB regulatory system in Acinetobacter baumannii

(2018) Yannick Charretier et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Aminoglycoside Heteroresistance in Acinetobacter baumannii AB5075

(2018) Sarah E. Anderson et al.   mSphere

Heterogeneous Colistin-Resistance Phenotypes Coexisting in Stenotrophomonas maltophilia Isolates Influence Colistin Susceptibility Testing

(2018) Sònia Martínez-Servat et al.   Frontiers in Microbiology

Pharmacokinetics/pharmacodynamics of systemically administered polymyxin B against Klebsiella pneumoniae in mouse thigh and lung infection models

(2017) Cornelia B Landersdorfer et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Unstable tandem gene amplification generates heteroresistance (variation in resistance within a population) to colistin inSalmonella enterica

(2016) Karin Hjort et al.   MOLECULAR MICROBIOLOGY

Distinguishing between resistance, tolerance and persistence to antibiotic treatment

(2016) Asher Brauner et al.   NATURE REVIEWS MICROBIOLOGY

Antibiotic failure mediated by a resistant subpopulation in Enterobacter cloacae

(2016) Victor I. Band et al.   Nature Microbiology

Heteroresistance to Itraconazole Alters the Morphology and Increases the Virulence of Cryptococcus gattii

(2015) Gabriella Freitas Ferreira et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Impact of carbapenem heteroresistance among clinical isolates of invasive Escherichia coli in Chongqing, southwestern China

(2015) J.D. Sun et al.   CLINICAL MICROBIOLOGY AND INFECTION

Antimicrobial Heteroresistance: an Emerging Field in Need of Clarity

(2015) Omar M. El-Halfawy et al.   CLINICAL MICROBIOLOGY REVIEWS

Colistin Heteroresistance in Enterobacter cloacae Is Associated with Cross-Resistance to the Host Antimicrobial Lysozyme

(2014) Brooke A. Napier et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Irreproducible and Uninterpretable Polymyxin B MICs for Enterobacter cloacae and Enterobacter aerogenes

(2013) D. Landman et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Prevalence and analysis of microbiological factors associated with phenotypic heterogeneous resistance to carbapenems in Acinetobacter baumannii

(2012) Felipe Fernández Cuenca et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Genetic heterogeneity and cancer drug resistance

(2012) Nicholas C Turner et al.   LANCET ONCOLOGY

Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia

(2011) R. Khatib et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations

(2010) Sreenath V. Sharma et al.   CELL

Mutants with heteroresistance to amphotericin B and fluconazole in Candida

(2009) A.L.R. Claudino et al.   BRAZILIAN JOURNAL OF MICROBIOLOGY

Antimicrobial Susceptibility Testing: A Review of General Principles and Contemporary Practices

(2009) James H. Jorgensen et al.   CLINICAL INFECTIOUS DISEASES

Antimicrobial Susceptibility Testing: A Primer for Clinicians

(2009) Kristi M Kuper et al.   PHARMACOTHERAPY

Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan

(2008) S. Hofmann-Thiel et al.   EUROPEAN RESPIRATORY JOURNAL

Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies

(2008) Gopi Patel et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY